Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01733667 · ClinicalTrials.gov registry record · NA
A Prospective, Randomized, Multi-Center Evaluation of MediENT® Middle Turbinate Implant Versus MeroPack®, a Bioresorbable Nasal Dressing / Sinus Stent After Endoscopic Sinus Surgery
A NA study of Synechia, sponsored by ENTrigue Surgical.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 5
- Study locations
NCT01733667: Completed NA study of Synechia, sponsored by ENTrigue Surgical.
NCT01733667 is a NA study of Synechia that has completed, run by ENTrigue Surgical. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01733667, a NA study of Synechia, has completed, sponsored by ENTrigue Surgical.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 5
- Study locations
Study Summary
The purpose of this study is to compare the safety and effectiveness of MediENT to MeroPack after FESS.
Primary Outcome
Miller synechia score at 8 weeks (Number and degree of synechia present between middle turbinate and lateral nasal wall at 8 weeks judged by an independent evaluator)
Conditions Studied
Interventions
- DEVICE MediENT
- DEVICE MeroPack
Study Locations (5)
Texas
- ENT Associates of Texas - McKinney
- Ear, Nose & Throat Clinics of San Antonio - San Antonio
California
- Central California ENT Medical Group - Fresno
Colorado
- Colorado ENT & Allergy - Colorado Springs
Kentucky
- Advanced ENT and Allergy - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2011-12 |
| Est. Completion | 2013-02 |
| Phase | NA |
What the finished NCT01733667 record still lists
NCT01733667 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Synechia appearing as the primary indexed condition, and to 2 interventions - of which MediENT is the first listed.
NCT01733667 lists 5 locations in 4 states (Texas, California, Colorado).
Frequently Asked Questions
What is clinical trial NCT01733667 about?
NCT01733667 is a clinical study titled "A Prospective, Randomized, Multi-Center Evaluation of MediENT® Middle Turbinate Implant Versus MeroPack®, a Bioresorbable Nasal Dressing / Sinus Stent After Endoscopic Sinus Surgery". The purpose of this study is to compare the safety and effectiveness of MediENT to MeroPack after FESS.
What is the current status of trial NCT01733667?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2011-12. Estimated completion is 2013-02.
What conditions does trial NCT01733667 study?
This clinical trial studies the following conditions: Synechia.
What interventions are being tested in trial NCT01733667?
The interventions under investigation include: MediENT (DEVICE), MeroPack (DEVICE).
Who is sponsoring clinical trial NCT01733667?
This trial is sponsored by ENTrigue Surgical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01733667 being conducted?
This trial has 5 study locations across California, Colorado, Kentucky, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01733667's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia